Despite reduced expression of canonical cytotoxic markers CD16 and CD56, TGF-β expanded γδ T cells displayed superior anti-tumor efficacy compared to standard IL2/ZOL expanded γδ T cells in an OS lung metastasis model when combined with ZOL and IFO. The gene discussed is NCAM1; the disease is neoplasm.